Gardasil 9 syringe 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FGNW8
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,171
Award facts
- Contract value 100% obligated
- $14,170.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $14,170.80 to DMS Pharmaceutical Group Inc. for the supply of GARDASIL 9 syringes (0.5ML) with an ultimate completion date of January 23, 2026. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation, demonstrating its competitive capability in unrestricted federal procurement. The delivery order will be performed at the vendor's Park Ridge facility and represents a routine pharmaceutical supply requirement within the Defense Logistics Agency's medical supply operations.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (SPE2DR) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which was established on November 13, 2025, with a $499.999 billion ceiling value and term extending through December 31, 2036. The PPV-G GEN V represents a $30.3 billion acquisition strategy designed to support the Department of Defense's pharmaceutical supply needs across military healthcare facilities worldwide. As a regional prime vendor contractor under this framework, DMS Pharmaceutical Group supplies a comprehensive range of pharmaceuticals including branded and generic prescription medications, biologics, vaccines, and medical consumables to support recurring military medical supply requirements globally.
Quick answers
Who was awarded contract SPE2DR26FGNW8?
SPE2DR26FGNW8 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26FGNW8 worth?
The government has obligated $14,171 on SPE2DR26FGNW8.
Is contract SPE2DR26FGNW8 an order under another contract?
Yes. SPE2DR26FGNW8 is a delivery order under SPE2DR25D9833, an indefinite delivery contract.
Was contract SPE2DR26FGNW8 competed?
The extent of competition for SPE2DR26FGNW8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award